Clinical Trials Browser

Phase 1 × Recruiting × Vorinostat × Clear all

NCT05317403 2026-01-12

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute